GSGlenda Aparecida Peres dos Santos

Glenda Aparecida Peres dos Santos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Glenda Aparecida Peres dos Santos has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Role of Chest Radiography in the COVID-19 Pandemic: Retrospective Study of Patients from a University Hospital in Brazil

    by Glenda Aparecida Peres dos Santos, Hanna da Silva Bessa da Costa, Carmem Moulin Magalhaes, Carolina Gianella Cobo Chantong, Roberto Mogami, Agnaldo José Lopes

    In December 2019, the World Health Organization (WHO) reported an outbreak of pneumonia in Wuhan, China, caused by severe acute respiratory syndrome coronavirus 2. Computed tomography (CT) is the primary imaging modality used to diagnose and monitor severe acute respiratory syndrome caused by SARS-CoV-2. However, its routine use is expensive and produces large amounts of radiation. The aim of this study was to define chest radiography (CXR) patterns for COVID-19 and correlate them with clinical and outcome variables to achieve early and effective diagnosis using a cheaper and more accessible imaging method compared to CT. We analyzed CXR images and RT-PCR results of patients with COVID-19, categorizing them into typical, possible, atypical, or negative patterns. The results showed that CXR is effective and economical in evaluating COVID-19, with type 3 opacities associated with more severe outcomes and type 1 opacities with early stages of infection. Moreover, patients with comorbidities, age over 60 years, and the need for mechanical ventilation had worse outcomes. In conclusion, CXR can be an effective and inexpensive tool in the evaluation of COVID-19, especially in high-demand scenarios. Standardization of radiographic findings is also important for the improvement of diagnostic accuracy and clinical management of COVID-19.

  • Open Access

    Assessing Severity in Patients with COVID-19 Using Chest Computed Tomography: A Retrospective Study of Patients from a University Hospital in Southeastern Brazil

    by Hanna da Silva Bessa da Costa, Carolina Gianella Cobo Chantong, Glenda Aparecida Peres dos Santos, Sarah Moreira Macedo, Carmem Moulin de Magalhães, Carlos Miguel Brum Queiroz da Cruz, Sthefane Louise Gomes Nunes, Agnaldo José Lopes, Roberto Mogami

    Coronavirus disease 2019 (COVID-19) was first described in Wuhan, China, in late 2019 and declared a pandemic by the World Health Organization (WHO) in March 2020. The present study aimed to characterize the clinical and chest computed tomography (CT) findings in a sample of patients with COVID-19 and to correlate them with the outcome of death. The specific objectives were to characterize the sample epidemiologically and to describe the tomographic patterns found. This retrospective, observational, and cross-sectional study analyzed associations between chest CT findings and outcomes in COVID-19 patients from a university hospital in southeastern Brazil, from April 2020 to June 2021. The most frequent symptoms included cough, dyspnea, fever, myalgia, chest pain, anosmia, and odynophagia. Common CT findings, in descending order, were ground-glass opacities, consolidations, mosaic paving, parenchymal bands, peribronchovascular consolidations, bronchial ectasia, subpleural lines, nodules with ground-glass halos, architectural distortion, and ground-glass bands. Patients with age ≥60 years and comorbidities were significant risk factors for mortality. Patients with >50% parenchymal involvement and indeterminate/atypical CT patterns also had a higher risk of death. While serological tests remain critical for diagnosis, this study highlights the importance of imaging in guiding treatment protocols, especially given the delays in test results.

  • Open Access

    The Importance of Radiological Patterns and Small Airway Disease in Long-Term Follow-Up of Postacute COVID-19: A Preliminary Study

    by Roberto Mogami, Ronaldo Carvalho Araújo Filho, Carolina Gianella Cobo Chantong, Fernando Carlos Santos de Almeida, Ana Célia Baptista Koifman, Gustavo Federico Jauregui, Thiago Thomaz Mafort, Hanna da Silva Bessa da Costa, Glenda Aparecida Peres dos Santos, Bruna Zangerolame de Carvalho, et al.

    Postacute COVID-19 has become a relevant public health problem, and radiological and pulmonary function tests are tools that help physicians in decision-making. The objectives of this study are to characterize the findings and patterns on a chest radiograph (CXR) and computed tomography (CT) that are most important in the postacute phase and to evaluate how these changes correlate with clinical data, spirometry, and impulse oscillometry (IOS). This was a retrospective study of 29 patients who underwent CXR, CT, spirometry, and IOS. The inclusion criteria were age >18 years and persistent respiratory symptoms after four weeks. The exclusion criteria were radiological exams with low technical quality and non-COVID-19 acute lung diseases. The inferential analysis was carried out with the chi-square (χ2) or Fisher’s exact test to evaluate the interrelationships between the clinical and COVID-19 variables according to spirometry, IOS, CT, and CXR. In our sample, 19 patients were women (65.5%). The predominance of abnormal spirometry was associated with CT’s moderate/severe degree of involvement ( = 0.017; 69.2%, CI 95%: 44.1%–94.3%). There was no significant association between IOS and tomographic and radiographic parameters. A significant association was found between the classifications of the moderate/severe and normal/mild patterns on CT and CXRs ( = 0.003; 93.3%, CI 95%: 77.8%–100%). Patients with moderate/severe impairment on CXR were associated with a higher frequency of hospitalization ( = 0.033; 77.8%, CI 95%: 58.6%–97.0%) and had significantly more moderate/severe classifications in the acute phase than the subgroup with normal/mild impairment on CXR ( = 0.017; 88.9%, CI 95%: 74.4%–100%). In conclusion, the results of this study show that CXR is a relevant examination and may be used to detect nonspecific alterations during the follow-up of post-COVID-19 patients. Small airway disease is an important finding in postacute COVID-19 syndrome, and we postulate a connection between this pattern and the persistently low-level inflammatory state of the lung.